EMIS Health
Financials
Estimates*
| GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 159m | 160m | 150m | 160m | 159m | 168m | 175m |
| % growth | 2 % | 1 % | (7 %) | 7 % | - | 6 % | 4 % |
| EBITDA | 43.6m | 31.7m | 51.2m | 49.6m | 53.1m | 52.9m | 44.7m |
| % EBITDA margin | 27 % | 20 % | 34 % | 31 % | 33 % | 31 % | 25 % |
| Profit | 20.1m | 8.9m | 22.8m | 22.0m | 30.1m | 29.1m | 33.2m |
| % profit margin | 13 % | 6 % | 15 % | 14 % | 19 % | 17 % | 19 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
£3.0m | Early VC | ||
£2.6m | Early VC | ||
£3.1m | Acquisition | ||
| Total Funding | $7.4m | ||
Related Content
Recent News about EMIS Health
EditEMIS Health is a leading provider of healthcare software and solutions, focusing on creating integrated IT systems that connect various healthcare settings. The company serves a wide range of clients including GP surgeries, high street pharmacies, hospitals, and community services. Operating primarily in the healthcare market, EMIS Health's business model revolves around offering software solutions that streamline healthcare processes and improve patient care. The company generates revenue through the sale of its software products, subscriptions, and related services. EMIS Health has been instrumental in significant healthcare initiatives, such as powering 75 million Covid-19 vaccinations and supporting the NHS Transfer of Care Initiative. The company's flagship product, EMIS X, is a clinical platform designed to enable an integrated healthcare ecosystem, while EMIS X Analytics provides powerful data analytics capabilities. EMIS Health continues to innovate and expand its offerings, as evidenced by its acquisition of Edenbridge Healthcare.
Keywords: healthcare IT, integrated care, GP surgeries, pharmacies, hospitals, community services, EMIS X, analytics, software solutions, patient care.
